Mammalian neutral sphingomyelinases: Regulation and roles in cell signaling responses

NeuroMolecular Medicine

Volumn 12, Issue 4, 2010, Pages 320-330

  Wu, Bill X ^a   Clarke, Christopher J ^a   Hannun, Yusuf A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bioactive lipids; Ceramide; Neutral sphingomyelinase; nSMase2; SM; Sphingolipid

Indexed keywords

AMYLOID BETA PROTEIN; CERAMIDE; CYTOKINE; DAUNORUBICIN; NEUTRAL SPHINGOMYELINASE 1; NEUTRAL SPHINGOMYELINASE 2; NEUTRAL SPHINGOMYELINASE 3; PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BONE MALFORMATION; CARCINOGENESIS; CATALYSIS; CELL CYCLE ARREST; CELL HYPOXIA; CELL STRESS; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME LOCALIZATION; GENE MUTATION; HUMAN; INFLAMMATION; LIPID METABOLISM; LUNG VASOCONSTRICTION; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; CERAMIDES; HUMANS; INFLAMMATION; MICE; OXIDATIVE STRESS; RATS; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE;

MAMMALIA;

EID: 78649802553     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-010-8120-z     Document Type: Review

References (88)

1. S Adam-Klages D Adam K Wiegmann, et al. 1996 FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase Cell 86 937 947 1:CAS:528:DyaK28XlvV2nsLs%3D 10.1016/S0092-8674(00)80169-5 8808629 (Pubitemid 26336798)
2. I Aubin CP Adams S Opsahl, et al. 2005 A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse Nature Genetics 37 803 805 1:CAS:528:DC%2BD2MXmsFKlsrk%3D 10.1038/ng1603 16025116 (Pubitemid 41077104)
3. N Bartke YA Hannun 2009 Bioactive sphingolipids: Metabolism and function Journal of Lipid Research 50 Suppl S91 S96 10.1194/jlr.R800080-JLR200 19017611
4. K Bernardo O Krut K Wiegmann, et al. 2000 Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain The Journal of Biological Chemistry 275 7641 7647 1:CAS:528: DC%2BD3cXitVyls7w%3D 10.1074/jbc.275.11.7641 10713073 (Pubitemid 30159665)
5. H Birbes SE Bawab LM Obeid YA Hannun 2002 Mitochondria and ceramide: Intertwined roles in regulation of apoptosis Advances in Enzyme Regulation 42 113 129 1:CAS:528:DC%2BD3sXoslyjsw%3D%3D 10.1016/S0065-2571(01)00026-7 12123710 (Pubitemid 35033533)
6. YM Chae SH Heo JY Kim JM Lee HM Ryoo JY Cho 2009 Upregulation of smpd3 via BMP2 stimulation and Runx2 BMB Reports 42 86 90 1:CAS:528: DC%2BD1MXjt12gsrk%3D 19250608
7. CE Chalfant S Spiegel 2005 Sphingosine 1-phosphate and ceramide 1-phosphate: Expanding roles in cell signaling Journal of Cell Science 118 4605 4612 1:CAS:528:DC%2BD2MXht1CnurzP 10.1242/jcs.02637 16219683 (Pubitemid 41646371)
8. CJ Clarke JM Guthrie YA Hannun 2008 Regulation of neutral sphingomyelinase-2 (nSMase2) by tumor necrosis factor-alpha involves protein kinase C-delta in lung epithelial cells Molecular Pharmacology 74 1022 1032 1:CAS:528:DC%2BD1cXht1Sgtb%2FM 10.1124/mol.108.046250 18653803
9. CJ Clarke YA Hannun 2006 Neutral sphingomyelinases and nSMase2: Bridging the gaps Biochimica et Biophysica Acta 1758 1893 1901 1:CAS:528: DC%2BD28Xht12kt7%2FE 10.1016/j.bbamem.2006.06.025 16938269 (Pubitemid 44879364)
10. CJ Clarke CF Snook M Tani N Matmati N Marchesini YA Hannun 2006 The extended family of neutral sphingomyelinases Biochemistry 45 11247 11256 1:CAS:528:DC%2BD28XovVaht70%3D 10.1021/bi061307z 16981685 (Pubitemid 44453973)
11. CJ Clarke TG Truong YA Hannun 2007 Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2 The Journal of Biological Chemistry 282 1384 1396 1:CAS:528:DC%2BD2sXit1Kruw%3D%3D 10.1074/jbc.M609216200 17085432 (Pubitemid 47076577)
12. A Cogolludo L Moreno G Frazziano, et al. 2009 Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction Cardiovascular Research 82 296 302 1:CAS:528:DC%2BD1MXksVaktL0%3D 10.1093/cvr/cvn349 19088082
13. DC Coleman JP Arbuthnott HM Pomeroy TH Birkbeck 1986 Cloning and expression in Escherichia coli and Staphylococcus aureus of the beta-lysin determinant from Staphylococcus aureus: Evidence that bacteriophage conversion of beta-lysin activity is caused by insertional inactivation of the beta-lysin determinant Microbial Pathogenesis 1 549 564 1:CAS:528:DyaL2sXksVyjsw%3D%3D 10.1016/0882-4010(86)90040-9 3334158 (Pubitemid 17222446)
14. CA Corcoran Q He S Ponnusamy B Ogretmen Y Huang MS Sheikh 2008 Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies Molecular Cancer Research 6 795 807 1:CAS:528:DC%2BD1cXmt1OjsLk%3D 10.1158/1541-7786.MCR-07-2097 18505924
15. C De Palma E Meacci C Perrotta P Bruni E Clementi 2006 Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: A novel pathway relevant to the pathophysiology of endothelium Arteriosclerosis, Thrombosis, and Vascular Biology 26 99 105 10.1161/01.ATV.0000194074.59584.42 16269668 (Pubitemid 43732234)
16. RD Duan 2006 Alkaline sphingomyelinase: An old enzyme with novel implications Biochimica et Biophysica Acta 1761 281 291 1:CAS:528: DC%2BD28XktVenurY%3D 16631405
17. M El Alwani BX Wu LM Obeid YA Hannun 2006 Bioactive sphingolipids in the modulation of the inflammatory response Pharmacology and Therapeutics 112 171 183 1:CAS:528:DC%2BD28XptFCitrk%3D 10.1016/j.pharmthera.2006.04.004 16759708 (Pubitemid 44301491)
18. AC Fensome F Rodrigues-Lima M Josephs HF Paterson M Katan 2000 A neutral magnesium-dependent sphingomyelinase isoform associated with intracellular membranes and reversibly inhibited by reactive oxygen species The Journal of Biological Chemistry 275 1128 1136 1:CAS:528:DC%2BD3cXntlegsw%3D%3D 10.1074/jbc.275.2.1128 10625655 (Pubitemid 30051163)
19. AH Futerman 2006 Intracellular trafficking of sphingolipids: Relationship to biosynthesis Biochimica et Biophysica Acta 1758 1885 1892 1:CAS:528:DC%2BD28Xht12kt7%2FL 10.1016/j.bbamem.2006.08.004 16996025 (Pubitemid 44879366)
20. R Goswami M Ahmed J Kilkus T Han SA Dawson G Dawson 2005 Differential regulation of ceramide in lipid-rich microdomains (rafts): Antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2 Journal of Neuroscience Research 81 208 217 1:CAS:528:DC%2BD2MXlvFGjs70%3D 10.1002/jnr.20549 15929065 (Pubitemid 41153334)
21. MO Grimm HS Grimm AJ Patzold, et al. 2005 Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin Nature Cell Biology 7 1118 1123 1:CAS:528:DC%2BD2MXht1WqtrjI 10.1038/ncb1313 16227967
22. YA Hannun LM Obeid 2008 Principles of bioactive lipid signalling: Lessons from sphingolipids Nature Reviews. Molecular Cell Biology 9 139 150 1:CAS:528:DC%2BD1cXovFOntg%3D%3D 10.1038/nrm2329 18216770 (Pubitemid 351158911)
23. He, X., Huang, Y., Li, B., Gong, C. X., & Schuchman, E. H. (2008). Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiology of Aging.
24. K Hofmann S Tomiuk G Wolff W Stoffel 2000 Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase Proceedings of the National Academy of Sciences of the United States of America 97 5895 5900 1:CAS:528:DC%2BD3cXjvFaktbk%3D 10.1073/pnas.97.11.5895 10823942 (Pubitemid 30367495)
25. K Horinouchi S Erlich DP Perl, et al. 1995 Acid sphingomyelinase deficient mice: A model of types A and B Niemann-Pick disease Nature Genetics 10 288 293 1:CAS:528:DyaK2MXms1Kjtbo%3D 10.1038/ng0795-288 7670466
26. H Ito M Murakami A Furuhata, et al. 2009 Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin Biochimica et Biophysica Acta 1789 681 690 1:CAS:528:DC%2BD1MXhsVajtbnO 19698806
27. A Jana EL Hogan K Pahan 2009 Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and death Journal of the Neurological Science 278 5 15 1:CAS:528:DC%2BD1MXhtlGkt7o%3D 10.1016/j.jns.2008.12.010
28. A Jana K Pahan 2004 Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease The Journal of Biological Chemistry 279 51451 51459 1:CAS:528:DC%2BD2cXhtVaqs73M 10.1074/jbc.M404635200 15452132 (Pubitemid 40017893)
29. A Jana K Pahan 2007 Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: Implications for multiple sclerosis Journal of Neuroimmune Pharmacology 2 184 193 10.1007/s11481-007-9066-2 18040843
30. RW Jenkins D Canals YA Hannun 2009 Roles and regulation of secretory and lysosomal acid sphingomyelinase Cell Signalling 6 836 846 10.1016/j.cellsig. 2009.01.026
31. M Josephs M Katan F Rodrigues-Lima 2002 Irreversible inactivation of magnesium-dependent neutral sphingomyelinase 1 (NSM1) by peroxynitrite, a nitric oxide-derived oxidant FEBS Letters 531 329 334 1:CAS:528:DC%2BD38Xotl2msrg%3D 10.1016/S0014-5793(02)03551-2 12417336 (Pubitemid 35341218)
32. TC Ju SD Chen CC Liu DI Yang 2005 Protective effects of S-nitrosoglutathione against amyloid beta-peptide neurotoxicity Free Radical Biology and Medicine 38 938 949 1:CAS:528:DC%2BD2MXitVCnsb4%3D 10.1016/j.freeradbiomed.2004.12.019 15749390 (Pubitemid 40326195)
33. SY Jung JH Suh HJ Park, et al. 2000 Identification of multiple forms of membrane-associated neutral sphingomyelinase in bovine brain Journal of Neurochemistry 75 1004 1014 1:CAS:528:DC%2BD3cXmtFyrsr8%3D 10.1046/j.1471-4159. 2000.0751004.x 10936181 (Pubitemid 30660488)
34. AA Karakashian NV Giltiay GM Smith MN Nikolova-Karakashian 2004 Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK activation The Faseb Journal 18 968 970 1:CAS:528:DC%2BD2cXkslWisbk%3D 15059969
35. WJ Kim RA Okimoto LE Purton, et al. 2008 Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias Blood 111 4716 4722 1:CAS:528:DC%2BD1cXlsVSrsL8%3D 10.1182/blood-2007-10-113068 18299447
36. RH Kim K Takabe S Milstien S Spiegel 2009 Export and functions of sphingosine-1-phosphate Biochimica et Biophysica Acta 1791 692 696 1:CAS:528:DC%2BD1MXnt1Gntrw%3D 19268560
37. K Kitatani J Idkowiak-Baldys YA Hannun 2008 The sphingolipid salvage pathway in ceramide metabolism and signaling Cell Signalling 20 1010 1018 1:CAS:528:DC%2BD1cXlsF2rt7s%3D 10.1016/j.cellsig.2007.12.006 18191382
38. A Kolmakova P Kwiterovich D Virgil, et al. 2004 Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase Arteriosclerosis, Thrombosis, and Vascular Biology 24 264 269 1:CAS:528:DC%2BD2cXnsFCntA%3D%3D 10.1161/01.ATV.0000112036.72200.ac 14670935 (Pubitemid 38202189)
39. O Krut K Wiegmann H Kashkar B Yazdanpanah M Kronke 2006 Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein The Journal of Biological Chemistry 281 13784 13793 1:CAS:528:DC%2BD28Xkt1ymuro%3D 10.1074/jbc.M511306200 16517606 (Pubitemid 43855294)
40. JT Lee J Xu JM Lee, et al. 2004 Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway The Journal of Cell Biology 164 123 131 1:CAS:528:DC%2BD2cXjs1Cksw%3D%3D 10.1083/jcb.200307017 14709545 (Pubitemid 38082463)
41. M Levy SS Castillo T Goldkorn 2006 nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis Biochemical and Biophysical Research Communications 344 900 905 1:CAS:528:DC%2BD28XktVOqtrY%3D 10.1016/j.bbrc.2006.04.013 16631623
42. M Levy E Khan M Careaga T Goldkorn 2009 Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death American Journal of Physiology Lung Cellular and Molecular Physiology 297 L125 L133 1:CAS:528:DC%2BD1MXovVKis78%3D 10.1152/ajplung.00031.2009 19395669
43. N Marchesini JA Jones YA Hannun 2007 Confluence induced threonine41/serine45 phospho-beta-catenin dephosphorylation via ceramide-mediated activation of PP1cgamma Biochimica et Biophysica Acta 1771 1418 1428 1:CAS:528:DC%2BD1cXptlSrtQ%3D%3D 17996206
44. N Marchesini C Luberto YA Hannun 2003 Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism The Journal of Biological Chemistry 278 13775 13783 1:CAS:528:DC%2BD3sXjtVSit70%3D 10.1074/jbc.M212262200 12566438 (Pubitemid 36799914)
45. N Marchesini W Osta J Bielawski C Luberto LM Obeid YA Hannun 2004 Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells The Journal of Biological Chemistry 279 25101 25111 1:CAS:528:DC%2BD2cXksFyhurs%3D 10.1074/jbc.M313662200 15051724 (Pubitemid 38756759)
46. N Matmati YA Hannun 2008 Thematic review series: Sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases Journal of Lipid Research 49 922 928 1:CAS:528: DC%2BD1cXltFSltrs%3D 10.1194/jlr.R800004-JLR200 18305313
47. Milhas, D., Clarke, C. J., & Hannun, Y. A. (2009) Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids. The FEBS Letters.
48. Y Mizutani K Tamiya-Koizumi N Nakamura M Kobayashi Y Hirabayashi S Yoshida 2001 Nuclear localization of neutral sphingomyelinase 1: Biochemical and immunocytochemical analyses Journal of Cell Science 114 3727 3736 1:CAS:528:DC%2BD3MXot12nsr4%3D 11707524 (Pubitemid 33041054)
49. DE Modrak DV Gold DM Goldenberg 2006 Sphingolipid targets in cancer therapy Molecular Cancer Therapeutics 5 200 208 1:CAS:528:DC%2BD28XhvVelsrg%3D 10.1158/1535-7163.MCT-05-0420 16505092
50. A Morales H Lee FM Goni R Kolesnick JC Fernandez-Checa 2007 Sphingolipids and cell death Apoptosis 12 923 939 1:CAS:528:DC%2BD2sXksFamtr4%3D 10.1007/s10495-007-0721-0 17294080 (Pubitemid 46653290)
51. P Navas DM Fernandez-Ayala SF Martin, et al. 2002 Ceramide-dependent caspase 3 activation is prevented by coenzyme Q from plasma membrane in serum-deprived cells Free Radical Research 36 369 374 1:CAS:528: DC%2BD38XotFGms78%3D 10.1080/10715760290021207 12069099 (Pubitemid 35154084)
52. M Nikolova-Karakashian A Karakashian K Rutkute 2008 Role of neutral sphingomyelinases in aging and inflammation Sub-cellular Biochemistry 49 469 486 10.1007/978-1-4020-8831-5-18 18751923
53. M Nikolova-Karakashian ET Morgan C Alexander DC Liotta AH Merrill Jr 1997 Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11 The Journal of Biological Chemistry 272 18718 18724 1:CAS:528:DyaK2sXltVSgsbs%3D 10.1074/jbc.272.30.18718 9228043 (Pubitemid 27318216)
54. SA Novgorodov TI Gudz 2009 Ceramide and mitochondria in ischemia/reperfusion Journal of Cardiovascular Pharmacology 53 198 208 1:CAS:528:DC%2BD1MXjtlOhurw%3D 10.1097/FJC.0b013e31819b52d5 19247196
55. B Ogretmen YA Hannun 2004 Biologically active sphingolipids in cancer pathogenesis and treatment Nature Reviews Cancer 4 604 616 1:CAS:528: DC%2BD2cXmtVOhsb4%3D 10.1038/nrc1411 15286740 (Pubitemid 39025055)
56. B Otterbach W Stoffel 1995 Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease) Cell 81 1053 1061 1:CAS:528:DyaK2MXms1Kmt74%3D 10.1016/S0092-8674(05)80010-8 7600574
57. DK Perry 2002 Serine palmitoyltransferase: Role in apoptotic de novo ceramide synthesis and other stress responses Biochimica et Biophysica Acta 1585 146 152 1:CAS:528:DC%2BD3sXivVOqug%3D%3D 12531548
58. S Philipp M Puchert S Adam-Klages, et al. 2010 The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase Proceedings of the National Academy of Sciences of the United States of America 107 1112 1117 1:CAS:528:DC%2BC3cXhtFyks74%3D 10.1073/pnas.0908486107 20080539
59. L Puglielli BC Ellis AJ Saunders DM Kovacs 2003 Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis The Journal of Biological Chemistry 278 19777 19783 1:CAS:528:DC%2BD3sXktVaqtrc%3D 10.1074/jbc.M300466200 12649271 (Pubitemid 36799164)
60. F Rodrigues-Lima AC Fensome M Josephs J Evans RJ Veldman M Katan 2000 Structural requirements for catalysis and membrane targeting of mammalian enzymes with neutral sphingomyelinase and lysophospholipid phospholipase C activities. Analysis by chemical modification and site-directed mutagenesis The Journal of Biological Chemistry 275 28316 28325 1:CAS:528:DC%2BD3cXmsVKktLc%3D 10871611
61. K Rutkute RH Asmis MN Nikolova-Karakashian 2007 Regulation of neutral sphingomyelinase-2 by GSH: A new insight to the role of oxidative stress in aging-associated inflammation Journal of Lipid Research 48 2443 2452 1:CAS:528:DC%2BD2sXht1Kntr3I 10.1194/jlr.M700227-JLR200 17693623 (Pubitemid 350058755)
62. K Rutkute AA Karakashian NV Giltiay A Dobierzewska MN Nikolova-Karakashian 2007 Aging in rat causes hepatic hyperresposiveness to interleukin-1beta which is mediated by neutral sphingomyelinase-2 Hepatology 46 1166 1176 1:CAS:528:DC%2BD2sXht1aksrrL 10.1002/hep.21777 17668873 (Pubitemid 350144781)
63. H Sawai N Domae N Nagan YA Hannun 1999 Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C The Journal of Biological Chemistry 274 38131 38139 1:CAS:528:DC%2BD3cXkt1GrsA%3D%3D 10.1074/jbc.274.53.38131 10608884 (Pubitemid 30026885)
64. H Sawai Y Okamoto C Luberto, et al. 2000 Identification of ISC1 (YER019w) as inositol phosphosphingolipid phospholipase C in Saccharomyces cerevisiae The Journal of Biological Chemistry 275 39793 39798 1:CAS:528:DC%2BD3cXptFSrurk%3D 10.1074/jbc.M007721200 11006294 (Pubitemid 32059011)
65. PB Schneider EP Kennedy 1967 Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease Journal of Lipid Research 8 202 209 1:CAS:528:DyaF2sXktVShurc%3D 4962590
66. EH Schuchman 2007 The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease Journal of Inherited Metabolic Disease 30 654 663 1:CAS:528:DC%2BD2sXhtFCgsr3N 10.1007/s10545-007-0632-9 17632693 (Pubitemid 47559876)
67. Schulze, J., Albers, J., Baranowsky, A., et al. (2009). Osteolytic prostate cancer cells induce the expression of specific cytokines in bone-forming osteoblasts through a Stat3/5-dependent mechanism. Bone.
68. G Somenzi G Sala S Rossetti M Ren R Ghidoni N Sacchi 2007 Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid PLoS One 2 e836 10.1371/journal.pone.0000836 17786207 (Pubitemid 351420083)
69. W Stoffel 1999 Functional analysis of acid and neutral sphingomyelinases in vitro and in vivo Chemistry and Physics of Lipids 102 107 121 1:CAS:528:DyaK1MXmt1emtL8%3D 10.1016/S0009-3084(99)00079-1 11001565 (Pubitemid 29438663)
70. W Stoffel B Jenke B Block M Zumbansen J Koebke 2005 Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development Proceedings of the National Academy of Sciences of the United States of America 102 4554 4559 1:CAS:528:DC%2BD2MXivFCqsrs%3D 10.1073/pnas.0406380102 15764706 (Pubitemid 40397150)
71. W Stoffel B Jenke B Holz, et al. 2007 Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression American Journal of Pathology 171 153 161 1:CAS:528:DC%2BD2sXosVals70%3D 10.2353/ajpath.2007.061285 17591962 (Pubitemid 47339235)
72. M Tani YA Hannun 2007 Analysis of membrane topology of neutral sphingomyelinase 2 FEBS Letters 581 1323 1328 1:CAS:528:DC%2BD2sXjsVWnsrc%3D 10.1016/j.febslet.2007.02.046 17349629 (Pubitemid 46452606)
73. M Tani YA Hannun 2007 Neutral sphingomyelinase 2 is palmitoylated on multiple cysteine residues. Role of palmitoylation in subcellular localization The Journal of Biological Chemistry 282 10047 10056 1:CAS:528: DC%2BD2sXjtlCisLk%3D 10.1074/jbc.M611249200 17272284 (Pubitemid 47104605)
74. AE Tcherkasowa S Adam-Klages ML Kruse, et al. 2002 Interaction with factor associated with neutral sphingomyelinase activation, a WD motif-containing protein, identifies receptor for activated C-kinase 1 as a novel component of the signaling pathways of the p55 TNF receptor Journal of Immunology 169 5161 5170 (Pubitemid 35217186)
75. E Tellier A Negre-Salvayre B Bocquet, et al. 2007 Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/ sphingolipid mitogenic pathway Molecular and Cellular Biology 27 2997 3007 1:CAS:528:DC%2BD2sXkt1OgtLo%3D 10.1128/MCB.01485-06 17283058 (Pubitemid 46581313)
76. AD Tepper P Ruurs J Borst WJ van Blitterswijk 2001 Effect of overexpression of a neutral sphingomyelinase on CD95-induced ceramide production and apoptosis Biochemical and Biophysical Research Communications 280 634 639 1:CAS:528:DC%2BD3MXls1aguw%3D%3D 10.1006/bbrc.2000.4166 11162568 (Pubitemid 32924477)
77. S Tomiuk K Hofmann M Nix M Zumbansen W Stoffel 1998 Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling? Proceedings of the National Academy of Sciences of the United States of America 95 3638 3643 1:CAS:528:DyaK1cXitlKjsbg%3D 10.1073/pnas.95.7.3638 9520418 (Pubitemid 28173180)
78. S Tomiuk M Zumbansen W Stoffel 2000 Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase The Journal of Biological Chemistry 275 5710 5717 1:CAS:528:DC%2BD3cXhsFKktL0%3D 10.1074/jbc.275.8.5710 10681556 (Pubitemid 30115212)
79. L Tonnetti MC Veri E Bonvini L D'Adamio 1999 A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction The Journal of Experimental Medicine 189 1581 1589 1:CAS:528:DyaK1MXjt1SktbY%3D 10.1084/jem.189.10.1581 10330437 (Pubitemid 29240883)
80. JE Vance R Steenbergen 2005 Metabolism and functions of phosphatidylserine Progress in Lipid Research 44 207 234 1:CAS:528: DC%2BD2MXmt1Srsbo%3D 10.1016/j.plipres.2005.05.001 15979148 (Pubitemid 40973811)
81. D Wheeler E Knapp VV Bandaru, et al. 2009 Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors Journal of Neurochemistry 109 1237 1249 1:CAS:528:DC%2BD1MXntVCju7g%3D 10.1111/j.1471-4159.2009.06038.x 19476542
82. JS Won YB Im M Khan AK Singh I Singh 2004 The role of neutral sphingomyelinase produced ceramide in lipopolysaccharide-mediated expression of inducible nitric oxide synthase Journal of Neurochemistry 88 583 593 1:CAS:528:DC%2BD2cXhtVaisbw%3D 10.1046/j.1471-4159.2003.02165.x 14720208 (Pubitemid 38140203)
83. T Yabu S Imamura M Yamashita T Okazaki 2008 Identification of Mg2+-dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis The Journal of Biological Chemistry 283 29971 29982 1:CAS:528:DC%2BD1cXht1ynt7bO 10.1074/jbc.M805402200 18678863
84. T Yabu A Shimuzu M Yamashita 2009 A novel mitochondrial sphingomyelinase in zebrafish cells The Journal of Biological Chemistry 284 20349 20363 1:CAS:528:DC%2BD1MXos1ensbs%3D 10.1074/jbc.M109.004580 19429680
85. A Yamada N Tsukagoshi S Udaka, et al. 1988 Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus cereus European Journal of Biochemistry 175 213 220 1:CAS:528:DyaL1MXntVWhtA%3D%3D 10.1111/j.1432-1033.1988.tb14186.x 2841128
86. DI Yang CH Yeh S Chen J Xu CY Hsu 2004 Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide Neurobiology of Disease 17 99 107 1:CAS:528:DC%2BD2cXntlaqsr4%3D 10.1016/j.nbd.2004.06.001 15350970 (Pubitemid 39209317)
87. W Zheng J Kollmeyer H Symolon, et al. 2006 Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy Biochimica et Biophysica Acta 1758 1864 1884 1:CAS:528:DC%2BD28Xht12kt7%2FK 10.1016/j.bbamem.2006.08.009 17052686 (Pubitemid 44879367)
88. M Zumbansen W Stoffel 2002 Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease Molecular and Cellular Biology 22 3633 3638 1:CAS:528:DC%2BD38XjslWlsbs%3D 10.1128/MCB.22.11.3633-3638.2002 11997500 (Pubitemid 34525207)